Sponsor or institution
Clinical trials and research at Northern Jiangsu People's Hospital
As of November 12, 2026, Find a Trial lists 16 clinical trials run by Northern Jiangsu People's Hospital that are recruiting, in China. By phase: Phase 2 (3), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 16Clinical trials
- 1Country
Newest trials
All recruiting trials (16)
-
Laparoscopic liver and spleen removal for small liver cancer in people with cirrhosis and enlarged spleen
This study tests whether removing part of the liver and the spleen during one operation helps people with small liver cancers and hypersplenism by improving liver function and immune balance.
-
Vagus nerve–guided laparoscopic spleen removal with azygoportal disconnection
This procedure tests whether a vagus nerve–guided laparoscopic spleen removal plus azygoportal disconnection helps people with cirrhosis, portal hypertension, and hypersplenism who have had gastroesophageal variceal bleeding.
-
Apixaban for portal vein clots that appear more than a year after laparoscopic splenectomy
This trial tests whether taking apixaban twice daily can treat portal vein blood clots that develop more than a year after laparoscopic splenectomy in people with cirrhosis.
-
Apixaban for portal vein thrombosis occurring more than one year after laparoscopic splenectomy and azygoportal disconnection
This trial will try whether taking apixaban 2.5 mg twice daily can treat portal vein clots that appear more than a year after laparoscopic splenectomy and azygoportal disconnection in people with cirrhosis.
-
Hydrocortisone plus fludrocortisone for adults with septic shock
This test will see if adding fludrocortisone to hydrocortisone helps adults with septic shock survive and recover circulation faster.
-
Icaritin plus mFOLFOX after surgery for high-risk hepatocellular carcinoma
This study will try giving oral Icaritin together with postoperative hepatic arterial infusion chemotherapy (mFOLFOX) to adults with hepatocellular carcinoma who have high-risk features for recurrence after curative surgery.
-
Postoperative hepatic arterial infusion of mFOLFOX for high‑risk hepatocellular carcinoma
This trial tests whether giving up to two courses of mFOLFOX directly into the liver artery after curative surgery can lower recurrence in adults with hepatocellular carcinoma who have high‑risk features.
-
Link between advanced glycation end products and stomach movement problems in diabetic gastroparesis
This project will see if levels of advanced glycation end products (AGEs) in blood and stomach tissue are linked to stomach movement problems in adults with diabetic gastroparesis.
-
Laparoscopic partial removal of the spleen for hypersplenism in cirrhosis.
This test tries whether removing part of the spleen by laparoscopy improves immune function and recovery in people with cirrhosis and hypersplenism.
-
Thread-embedding acupuncture to speed bowel recovery after colorectal cancer surgery.
This trial will test whether adding thread embedding acupuncture (with electroacupuncture) helps adults recover bowel function faster after elective laparoscopic colorectal cancer surgery.
-
Laparoscopic removal of splenic artery aneurysm with spleen preservation
This study tries a minimally invasive laparoscopic operation that removes splenic artery aneurysms while saving the spleen in patients with aneurysms that are large, ruptured, or growing quickly, and checks immune function and nearby blood flow over a year.
-
Tislelizumab plus thoracic radiotherapy before surgery for resectable non-small cell lung cancer
This will test whether giving tislelizumab together with thoracic radiotherapy before surgery helps people with resectable NSCLC.
-
CT-guided localization for small liver tumors before surgery
This study tests if using a special needle to pinpoint small liver tumors with CT scans before surgery can help doctors remove them more accurately for patients with cirrhosis.
-
Laparoscopic surgery to improve immune function in cirrhosis patients
This study is testing if a specific type of surgery can help boost the immune system in people with liver cirrhosis who have an enlarged spleen.
-
Surgery to improve liver function in cirrhosis patients
This study tests whether a specific surgery can help improve liver function in patients with cirrhosis who have an enlarged spleen.
-
Laparoscopic splenectomy's effect on liver function in cirrhosis patients
This study tests if a minimally invasive surgery to remove the spleen can improve liver function in patients with cirrhosis.
Quick answers
How many clinical trials run by Northern Jiangsu People's Hospital are recruiting right now?
16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.